Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Sign up for Newsletter  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace Innovative Strategies for Patient Centered Clinical Research
Site Search:
    Home Engaged Innovation Patient Engagement Events News Careers Directory

A Proof of Concept study is a trial to demonstrate clinical efficacy with a small number of strictly selected patients.

The objectives of the Proof of Concept Study:

  • Validation of the relevance of novel therapeutic targets and in vivo preclinical models to man. 
  • Define potential biological markets for clinical efficacy or toxicity. 
  • Provide earlier evidence of the potential to show clinical efficacy. 
  • Rapidly eliminate potential failures from the pipeline. 
  • Provide an assessment of the commercial potential of NCE development candidates.

It is essential to have well defined criteria for decision-making at all stages of the R&D process. This is particularly true for those that will result in a NO GO decision.

Potential GO/NO GO Decision criteria:

  • Safety 
  • Tolerability 
  • Bioavailability/Pharmacokinetics (PK) 
  • Biopharmaceutics 
  • Pharmacodynamics (PD) 
  •     Duration of action 
  •     Relationship between Dose and PD 
  • Efficacy 
  • Patient acceptability 
  • Commercial viability in the indication at potential time of launch

Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2018 CanBiotech™ Inc.